IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 34 filers reported holding IGM BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,272,147 | -8.1% | 870,916 | +1.6% | 0.00% | – |
Q2 2023 | $7,911,689 | -25.3% | 857,171 | +11.2% | 0.00% | – |
Q1 2023 | $10,587,989 | -21.1% | 770,596 | -2.4% | 0.00% | – |
Q4 2022 | $13,424,887 | -20.2% | 789,235 | +6.7% | 0.00% | -100.0% |
Q3 2022 | $16,827,000 | +29.0% | 739,932 | +2.2% | 0.00% | – |
Q2 2022 | $13,049,000 | -29.7% | 723,710 | +4.2% | 0.00% | -100.0% |
Q1 2022 | $18,573,000 | -6.5% | 694,824 | +2.6% | 0.00% | 0.0% |
Q4 2021 | $19,855,000 | -52.9% | 676,957 | +5.7% | 0.00% | 0.0% |
Q3 2021 | $42,134,000 | -20.0% | 640,737 | +1.3% | 0.00% | 0.0% |
Q2 2021 | $52,650,000 | -7.1% | 632,801 | -14.4% | 0.00% | -50.0% |
Q1 2021 | $56,680,000 | -11.0% | 739,045 | +2.5% | 0.00% | 0.0% |
Q4 2020 | $63,688,000 | +89.4% | 721,354 | +58.3% | 0.00% | +100.0% |
Q3 2020 | $33,631,000 | -17.1% | 455,640 | -18.0% | 0.00% | -50.0% |
Q2 2020 | $40,550,000 | +61.7% | 555,487 | +24.4% | 0.00% | +100.0% |
Q1 2020 | $25,079,000 | +97.3% | 446,640 | +34.1% | 0.00% | – |
Q4 2019 | $12,711,000 | +717.4% | 333,079 | +280.2% | 0.00% | – |
Q3 2019 | $1,555,000 | – | 87,615 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |